CD274 and neoplasm: Stratifying for PD-L1 expression, objective responses were observed in six out of 77 patients (8%) with PD-L1 positive tumor (median duration of response: 17.7 months) and in four out of 31 patients (13%) with PD-L1 negative tumor (median duration of response: 10.2 months).